Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 144 #1
TickerADNC [NASD]
CompanyAudience, Inc.
CountryUSA
IndustrySemiconductor - Integrated Circuits
Market Cap133.93MEPS (ttm)-0.77
P/E-EPS this Y-86.20%
Forward P/E-EPS next Y43.60%
PEG-EPS past 5Y16.20%
P/S0.95EPS next 5Y-3.30%
P/B0.86EPS Q/Q-281.80%
Dividend-Sales Q/Q-17.20%
Insider Own1.90%Inst Own94.20%
Insider Trans-68.41%Inst Trans2.83%
Short Float5.39%EarningsOct 30/a
Analyst Recom2.60Target Price9.43
Avg Volume158.92K52W Range5.81 - 13.59
30-Oct-14 10:55AMHarman International Beats Q1 Earnings, Revenues Zacks
30-Oct-14 07:07AMQ3 2014 Audience Inc Earnings Release - After Market Close CCBN
17-Oct-14 11:38AMAfter HBO And CBS, Who Will Be Next With Web Subscriptions? at Forbes
09-Oct-14 04:05PMAudience to Host Third Quarter Earnings Conference Call on October 30, 2014 Marketwired
08-Oct-14 06:30AMGT Advanced bankruptcy offers warning to Apple suppliers Reuters
25-Sep-14 08:00AMAudience Joins Smart Voice Alliance in China as a Charter Member Marketwired
24-Sep-14 05:13PMAUDIENCE INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhib EDGAR Online
18-Sep-14 07:46PMThere's a Downside to Making Parts for Apple at BusinessWeek
11-Sep-14 04:22PMAUDIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
20-Aug-14 04:09PMAudience to Participate in September Conferences Marketwired
Audience, Inc. provides voice and audio solutions for mobile devices in Korea, China, the United States, and internationally. Its platform consists of proprietary, purpose-built digital signal processors (DSPs) and audio codecs, analog and mixed signal circuits, and algorithms for voice isolation and noise suppression. The company offers voice and audio processors, including eS305, a second generation voice and audio processor for far-field wideband communications; eS310 that provides flexible connectivity to analog and digital interfaces; eS325, a third generation voice and audio processor for consistent voice call experience when moving between 3G and 4G networks; eS70x, which delivers a range of innovations in speech, voice, and multimedia audio processing, as well as delivers improved performance in third generation automatic speech recognition assist, bandwidth expansion, improved acoustic echo cancellation, and audio playback enhancements technologies; and eS75x that combines the eS70x advanced voice and audio processing capabilities with a high performance mixed-signal audio sub-system. It also provides AuViD graphical design tools that enable original equipment manufacturers (OEMs) to integrate and customize the features of its voice and audio processors in a multitude of device designs. The company sells its products to OEMs and their contract manufacturers through its direct sales force, third-party sales representatives, and distributors. The company was formerly known as Applied Neurosystems Corporation and changed its name to Audience, Inc. in June 2002. Audience, Inc. was founded in 2000 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schoenfield Robert HVP, Greater ChinaAug 20Option Exercise0.001,43719,609Aug 22 04:18 PM
SPADE THOMAS DVP, Sales & Bus. DevAug 20Option Exercise0.001,25019,650Aug 22 04:13 PM
Bernard AlexisChief Technology OfficerAug 20Option Exercise0.001,90026,271Aug 22 04:18 PM
Medina Eitan AsherVP of EngineeringAug 20Option Exercise0.001,3751114,847Aug 22 04:20 PM
Palatnik Kevin S.Chief Financial OfficerAug 20Option Exercise0.002,4002141,146Aug 22 04:21 PM
TickerAEGR [NASD]
CompanyAegerion Pharmaceuticals, Inc.
CountryUSA
IndustryBiotechnology
Market Cap968.65MEPS (ttm)-1.76
P/E-EPS this Y17.00%
Forward P/E20.49EPS next Y283.90%
PEG-EPS past 5Y36.30%
P/S9.33EPS next 5Y-
P/B9.08EPS Q/Q50.00%
Dividend-Sales Q/Q453.80%
Insider Own0.30%Inst Own93.70%
Insider Trans1.00%Inst Trans6.06%
Short Float33.89%EarningsOct 30/a
Analyst Recom1.80Target Price60.60
Avg Volume1.07M52W Range26.25 - 101.00
30-Oct-14 07:07AMQ3 2014 Aegerion Pharmaceuticals Inc Earnings Release - After Market Close CCBN
29-Oct-14 09:16AMAegerion Board Expresses Support for Embattled CEO Amid Drug Use Accusations at TheStreet
28-Oct-14 01:33PMSex, drugs and biotechs in nasty divorce case at CNBC
27-Oct-14 04:40PMWill Aegerion (AEGR) Disappoint This Earnings Season? Zacks
27-Oct-14 10:24AMAegerion, Seattle Genetics CEOs Accused in Suit of Cocaine Use at TheStreet
27-Oct-14 08:00AMAegerion Pharmaceuticals to Announce Third-Quarter 2014 Financial Results on Thursday, October 30 GlobeNewswire
17-Oct-14 02:48PMAEGERION PHARMACEUTICALS, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements EDGAR Online
08-Oct-14 04:05PMAegerion Pharmaceuticals Grants Stock Options Under Inducement Program GlobeNewswire
24-Sep-14 04:10PMAegerion Pharmaceuticals Announces Presentation at the Leerink Rare Disease Roundtable GlobeNewswire
24-Sep-14 09:00AMAegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day GlobeNewswire
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. The company's products include JUXTAPID (lomitapide) and LOJUXTA (lomitapide) hard capsules, an adjunct to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. It also has the right to use lomitapide in the field of monotherapy or in combination with other dyslipidemic therapies for treatment of patients with other severe forms of hypercholesterolemia. The company distributes its products directly to patients and other purchasers through a specialty pharmacy. Aegerion Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fitzpatrick Mark J.Chief Financial OfficerAug 19Buy30.641,15035,2369,500Aug 20 09:36 AM
Beer Marc DChief Executive OfficerJun 03Buy30.1210,000301,20069,400Jun 04 09:30 AM
Beer Marc DChief Executive OfficerMay 27Buy31.5910,000315,90059,400May 27 12:57 PM
Beer Marc DChief Executive OfficerMay 21Option Exercise1.546,4009,85649,400May 22 09:39 AM
Beer Marc DChief Executive OfficerMay 20Buy30.5310,000305,30043,000May 21 09:40 AM
TickerAFFX [NASD]
CompanyAffymetrix Inc.
CountryUSA
IndustryScientific & Technical Instruments
Market Cap595.11MEPS (ttm)-0.08
P/E-EPS this Y-53.30%
Forward P/E41.80EPS next Y8.38%
PEG-EPS past 5Y44.80%
P/S1.74EPS next 5Y27.80%
P/B2.20EPS Q/Q88.90%
Dividend-Sales Q/Q7.40%
Insider Own1.30%Inst Own96.60%
Insider Trans3.02%Inst Trans0.57%
Short Float14.22%EarningsOct 30/a
Analyst Recom2.90Target Price9.50
Avg Volume504.76K52W Range6.25 - 9.80
30-Oct-14 07:07AMQ3 2014 Affymetrix Inc Earnings Release - After Market Close CCBN
20-Oct-14 03:55PMAffymetrix-Ariosa Ink Supply Deal for Harmony Prenatal Test Zacks
20-Oct-14 06:30AMAffymetrix Exclusively Licenses Technology from Peptide Groove LLP for HLA Typing from Genotyping Data Business Wire
16-Oct-14 06:30AMAffymetrix and Ariosa Diagnostics Announce Signing of Multi-Year Supply Agreement in Support of Ariosas Non-Invasive Prenatal Test Business Wire
01-Oct-14 04:00PMAffymetrix to Report Third Quarter 2014 Operating Results on Thursday October 30, 2014 Business Wire
30-Sep-14 08:12AMZacks Rank #1 Additions for Tuesday Zacks
02-Sep-14 06:55AMShould Affymetrix (AFFX) Be On Your Radar Now? Zacks
21-Aug-14 12:30PMAffymetrix Still Recovers, Genetic Analysis Drives Growth Zacks
11-Aug-14 06:55AMWhy Affymetrix (AFFX) Could Be an Impressive Growth Stock Zacks
09-Aug-14 01:04PMAFFYMETRIX INC Financials EDGAR Online Financials
Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia. The company operates in two segments, Affymetrix Core and eBioscience. The Affymetrix Core segment is engaged in the development, manufacture, and commercialization of systems for genetic analysis in the life sciences and diagnostic industry. This segment develops and markets GeneChip gene expression products and services; genotyping product line, such as the Axiom product line; arrays and assays with clinical research applications, such as the CytoScan and OncoScan products; QuantiGene line of singleplex and multiplex assays to serve customers in the research and translational medicine markets; and GeneTitan family of products consisting of the GeneTitan instrument system that runs genotyping and gene expression array plates. It also offers life science reagents, such as ExoSAP-IT for a reagent for the clean-up of polymerase chain reaction, and HotStart-IT reagents to inhibit primer dimer formation; enzymes; purification kits; and biochemicals for life science researchers. The eBioscience segment is involved in the development, manufacturing, marketing, and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging, and other protein-based analyses. This segment offers a portfolio of antibodies and reagents, as well as a range of the QuantiGene and Procarta assay portfolio. The company sells its products directly and through third party distributors to genomic research centers, academic institutions, government, and private laboratories, as well as pharmaceutical, diagnostic, and biotechnology companies. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trice Robert HDirectorNov 19Sale7.986,20549,52453,199Nov 20 05:18 PM
TickerAGII [NASD]
CompanyArgo Group International Holdings, Ltd.
CountryBermuda
IndustryProperty & Casualty Insurance
Market Cap1.42BEPS (ttm)5.79
P/E9.40EPS this Y180.90%
Forward P/E13.51EPS next Y10.20%
PEG0.94EPS past 5Y22.50%
P/S0.94EPS next 5Y10.00%
P/B0.87EPS Q/Q28.30%
Dividend1.32%Sales Q/Q3.30%
Insider Own2.20%Inst Own89.40%
Insider Trans5.34%Inst Trans0.28%
Short Float2.36%EarningsOct 30/a
Analyst Recom2.50Target Price52.83
Avg Volume90.02K52W Range39.88 - 54.95
30-Oct-14 07:07AMQ3 2014 Argo Group International Holdings Ltd Earnings Release - After Market Close CCBN
28-Oct-14 08:18AMArgo Group Names Nigel Mortimer EVP Strategy & Business Development Business Wire
21-Oct-14 11:59AMBuy These 5 Financial Sector Breakout Stocks in October at TheStreet
16-Oct-14 08:02AMArgo Group Announces Investment in Newtopia, Inc. Business Wire
09-Oct-14 08:00AMArgo Group Schedules Its 2014 Third Quarter Earnings Release and Conference Call Business Wire
06-Oct-14 03:20PMArgo Group Ratings Affirmed by A.M. Best; AGII Stock Rises Zacks
06-Oct-14 08:53AMZacks Rank #1 Additions for Monday Zacks
02-Oct-14 04:59PMA.M. Best Affirms Ratings of Argo Group International Holdings, Ltd. and Its Subsidiaries Business Wire
18-Sep-14 03:10PMShould Agro Group (AGII) Stock Be in Your Portfolio Now? Zacks
03-Sep-14 03:01PMArgo Group Announces Investment in Gleason Technology Business Wire
Argo Group International Holdings, Ltd. operates as an underwriter of specialty insurance and reinsurance products in the property and casualty market worldwide. The company's Excess and Surplus Lines segment underwrites casualty, property, automobile, and professional liability coverage for contractors, manufacturers, distributors, property owners, retailers, restaurants, environmental consultants and contractors, and smaller medical facilities. This segment also offers errors and omissions, and management liability products for wholesale and retail distribution partners; and risk management solutions for accountants, architects and engineers, commercial crime, directors and officers, employment practices, fiduciary, lawyers, miscellaneous professionals, technology, privacy, and security customers. Its Commercial Specialty segment underwrites coverage for small commercial businesses comprising office, retail operations, light manufacturing, and restaurants; provides casualty, property, surety, auto, and umbrella coverage, as well as artisan contractor packages; and operates a non-risk-bearing agency. This segment also offers general and automobile liability, automobile physical damage, property, inland marine, crime, public official's and educator's legal liabilities, employment practices, law enforcement liability, and workers compensation coverage for small and intermediate-sized public sector entities. The company's International Specialty segment provides specialty property catastrophe reinsurance, and excess casualty and professional insurance; and underwrites general, products, directors and officers, errors and omissions, and employment practices liabilities for various clients; and underwrites coverage for cargo and marine, property and engineering, financial lines, and motor businesses. The Syndicate 1200 segment underwrites property, specialty, and non-U.S. liability insurance. The company was founded in 1986 and is headquartered in Pembroke, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bullock Jay StanleyChief Financial OfficerSep 04Option Exercise34.7810,000347,80067,243Sep 04 05:52 PM
Bullock Jay StanleyChief Financial OfficerSep 04Sale53.0010,000530,00057,243Sep 04 05:52 PM
Bullock Jay StanleyChief Financial OfficerSep 02Option Exercise34.7810,000347,80067,243Sep 04 05:52 PM
Bullock Jay StanleyChief Financial OfficerSep 02Sale53.0010,000530,00057,243Sep 04 05:52 PM
WATSON MARK E IIIPresident and CEOAug 25Sale52.7510,000527,482432,919Aug 27 04:25 PM
TickerAHS [NYSE]
CompanyAMN Healthcare Services Inc.
CountryUSA
IndustryStaffing & Outsourcing Services
Market Cap786.78MEPS (ttm)0.66
P/E25.64EPS this Y115.60%
Forward P/E21.02EPS next Y15.83%
PEG2.14EPS past 5Y-7.50%
P/S0.79EPS next 5Y12.00%
P/B3.36EPS Q/Q-16.70%
Dividend-Sales Q/Q-1.20%
Insider Own0.40%Inst Own93.30%
Insider Trans-13.89%Inst Trans0.06%
Short Float2.72%EarningsOct 30/a
Analyst Recom1.60Target Price16.75
Avg Volume313.81K52W Range10.35 - 17.12
30-Oct-14 07:07AMQ3 2014 AMN Healthcare Services Inc Earnings Release - After Market Close CCBN
02-Oct-14 12:00PMAMN Healthcare CEO Elected to McKesson Corporation Board of Directors PR Newswire
01-Oct-14 09:00AMAMN Healthcare to Host 2014 Third Quarter Earnings Conference Call on Thursday, October 30, 2014 PR Newswire
25-Sep-14 12:00PMAMN Healthcare Launches First-of-its Kind Center to Train the New Healthcare Workforce PR Newswire
11-Sep-14 09:08AMAMN Healthcare (AHS) Stock: Moving Average Crossover Alert Zacks
28-Aug-14 09:40AMCan the Uptrend Continue for AMN Healthcare (AHS)? Zacks
27-Aug-14 03:11PM[video] AMN Healthcare CEO: Demand Not Diminishing for Doctors, Nurses at TheStreet
27-Aug-14 06:00AMJim Cramer's Top Stock Picks: MNST PRGO LE AHS at TheStreet
26-Aug-14 08:25PMJim Cramer's 'Mad Money' Recap: A Monster of an August at TheStreet
26-Aug-14 06:44PMShortage of pros benefits this stock: Cramer at CNBC
AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. The company operates through three segments: Nurse and Allied Healthcare Staffing, Locum Tenens Staffing, and Physician Permanent Placement Services. The Nurse and Allied Healthcare Staffing segment offers a range of clinical workforce solutions, including a managed services workforce solution to manage the contingent needs for a client; a recruitment process outsourcing program that replaces or complements a client's existing internal recruitment function for permanent staffing needs; a vendor management system delivered through software as a service; and traditional staffing service solutions of local, short and long-term assignment lengths. The Locum Tenens Staffing segment places independent contractors physicians of various specialties, advanced practice clinicians, and dentists on a locum tenens basis with various healthcare organizations, including hospitals, health systems, medical groups, occupational medical clinics, psychiatric facilities, government institutions, and insurance companies. The Physician Permanent Placement Services segment provides physician permanent placement services to hospitals, healthcare facilities, and physician practice groups. It serves acute and sub-acute care hospitals, government facilities, community health centers and clinics, physician practice groups, and other healthcare settings. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jackson Denise LGeneral Counsel / Sr. V.P.Oct 20Option Exercise16.1818,402297,74480,613Oct 22 04:39 PM
Jackson Denise LGeneral Counsel / Sr. V.P.Oct 20Sale16.782644,43062,211Oct 22 04:39 PM
Henderson RalphPresident, Healthcare StaffingAug 21Sale15.001,81527,22577,205Aug 25 12:01 PM
Jackson Denise LGeneral Counsel / Sr. V.P.Aug 05Sale14.001,55021,70062,211Aug 06 06:08 PM
Scott Brian M.CFO/CAOAug 05Sale14.001,55021,70036,275Aug 06 06:30 PM
TickerAHT [NYSE]
CompanyAshford Hospitality Trust, Inc.
CountryUSA
IndustryREIT - Hotel/Motel
Market Cap969.69MEPS (ttm)-0.92
P/E-EPS this Y19.40%
Forward P/E-EPS next Y20.20%
PEG-EPS past 5Y-31.00%
P/S1.13EPS next 5Y15.00%
P/B1.61EPS Q/Q-450.00%
Dividend4.42%Sales Q/Q-19.20%
Insider Own0.50%Inst Own78.90%
Insider Trans9.30%Inst Trans-0.01%
Short Float4.34%EarningsOct 30/a
Analyst Recom2.40Target Price13.01
Avg Volume505.29K52W Range7.49 - 11.89
30-Oct-14 07:07AMQ3 2014 Ashford Hospitality Trust Inc Earnings Release - After Market Close CCBN
29-Oct-14 10:37AMASHFORD HOSPITALITY TRUST INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi EDGAR Online
29-Oct-14 06:41AMWhy Ashford Hospitality (AHT) Might Surprise This Earnings Season Zacks
27-Oct-14 05:21PMASHFORD HOSPITALITY TRUST INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
27-Oct-14 06:00AMAshford Trust Announces Corporate Governance Enhancements PR Newswire
15-Oct-14 04:22PMASHFORD HOSPITALITY TRUST INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an EDGAR Online
10-Oct-14 05:30PMASHFORD HOSPITALITY TRUST INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
02-Oct-14 09:31AMHigh-Flying REIT Lodging Sector Crashes: Ebola Concerns Or Profit Taking? Benzinga
29-Sep-14 08:00AMAshford Trust To Present At The JMP Financial Services & Real Estate Conference On Tuesday, September 30, 2014 PR Newswire
22-Sep-14 08:00AMAshford Trust Sets Third Quarter Earnings Release And Conference Call Dates PR Newswire
Ashford Hospitality Trust, Inc. is a publicly owned real estate investment trust. The firm engages in investment and management of properties in the hospitality industry. It invests in the real estate markets of the United States. The firm primarily invests in hotels with a focus on the ownership of upper-upscale and upscale full-service and select service hotels in primary, secondary and resort markets. It also invests in mid-scale and luxury hotels. The firm invests across all segments and at all levels of the capital structure, including direct hotel investments, first mortgages, mezzanine loans, construction loans, and sale-leaseback transactions. It primarily concentrates among Marriott, Hilton, Hyatt, and Starwood brands. Ashford Hospitality Trust, Inc. was founded in 1968 and is based in Dallas, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ansell Benjamin J MDDirectorNov 12Buy8.006,26050,08045,000Nov 12 05:33 PM
Callahan Thomas EDirectorNov 05Buy12.755,00063,75045,825Nov 12 05:03 PM
TALLIS ALANDirectorNov 04Sale12.9915,000194,850249,586Nov 05 06:47 PM
TickerAIV [NYSE, S&P 500]
CompanyApartment Investment and Management Company
CountryUSA
IndustryREIT - Residential
Market Cap5.01BEPS (ttm)0.29
P/E118.17EPS this Y148.30%
Forward P/E89.71EPS next Y-65.74%
PEG21.29EPS past 5Y15.60%
P/S5.17EPS next 5Y5.55%
P/B5.23EPS Q/Q50.00%
Dividend3.03%Sales Q/Q1.90%
Insider Own0.50%Inst Own99.80%
Insider Trans-19.85%Inst Trans0.11%
Short Float2.66%EarningsOct 30/a
Analyst Recom2.60Target Price35.27
Avg Volume1.06M52W Range24.18 - 34.87
30-Oct-14 07:07AMQ3 2014 Apartment Investment and Management Co Earnings Release - After Market Close CCBN
29-Oct-14 06:50PMAimco Announces Quarterly Common Dividend Business Wire
13-Oct-14 02:30PM[video] Street Talk: BAX, PAYX, GGG, HSIC & AIV at CNBC
06-Oct-14 04:30PMAimco Announces Dates for Third Quarter 2014 Earnings Release and Conference Call Business Wire
10-Sep-14 04:50PMApartment Investment and Management Company Declares Dividends on Class A and Z Cumulative Preferred Stock Business Wire
10-Sep-14 07:47AMAPARTMENT INVESTMENT & MANAGEMENT CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
08-Sep-14 05:40PMAimco Riding on Growth Path with Portfolio Boosting Efforts Zacks
08-Sep-14 05:04PMAimco Announces Participation in Bank of America Merrill Lynch 2014 Global Real Estate Conference Business Wire
04-Sep-14 10:30AMAimco (AIV) Stock Hits 52-Week High: Right Time to Buy It? Zacks
03-Sep-14 07:19AMSelect Income REIT (SIR) Crumbles: Stock Falls by 5.5% Zacks
Apartment Investment and Management Company is a real estate investment trust. The firm engages in the acquisition, ownership, management, and redevelopment of apartment properties. It invests in real estate markets of United States. The firm primarily invests in apartment properties. Apartment Investment and Management Company was founded on January 10, 1994 and is headquartered in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CORTEZ MILESExecutive Vice PresidentAug 21Sale34.285,997205,553120,518Aug 22 06:34 PM
CORTEZ MILESExecutive Vice PresidentAug 20Sale34.081,03135,136126,515Aug 22 06:34 PM
BAILEY JAMES NDirectorAug 08Sale33.2110,000332,09352,587Aug 11 06:20 PM
CONSIDINE TERRYChairman & CEOAug 07Sale33.1999,0513,287,206340,280Aug 11 06:23 PM
BAILEY JAMES NDirectorAug 06Sale33.3917,500584,26062,587Aug 07 06:13 PM
TickerALJ [NYSE]
CompanyAlon USA Energy, Inc.
CountryUSA
IndustryOil & Gas Refining & Marketing
Market Cap1.05BEPS (ttm)-0.78
P/E-EPS this Y-72.40%
Forward P/E15.26EPS next Y14.45%
PEG-EPS past 5Y-28.60%
P/S0.15EPS next 5Y10.00%
P/B1.70EPS Q/Q-164.70%
Dividend2.65%Sales Q/Q4.00%
Insider Own62.30%Inst Own40.50%
Insider Trans0.51%Inst Trans-8.07%
Short Float37.83%EarningsOct 30/a
Analyst Recom2.30Target Price20.00
Avg Volume1.01M52W Range9.69 - 17.40
30-Oct-14 07:45AMAlon USA Partners Announces Third Quarter 2014 Earnings Release And Conference Call Schedule PR Newswire
30-Oct-14 07:45AMAlon USA Announces Third Quarter 2014 Earnings Release and Conference Call Schedule PR Newswire
30-Oct-14 07:07AMQ3 2014 Alon USA Energy Inc Earnings Release - After Market Close CCBN
30-Oct-14 06:03AMALON USA ENERGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princ EDGAR Online
29-Oct-14 04:15PMAlon USA Partners, LP Reports Third Quarter 2014 Results and Declares Quarterly Cash Distribution PR Newswire
29-Oct-14 02:53PMWill Crude Reality Hurt ConocoPhillips (COP) Q3 Earnings? Zacks
28-Oct-14 02:40PMHess Corporation (HES): Will Earnings Disappoint in Q3? Zacks
27-Oct-14 03:10PMWilliams Companies (WMB): Will it Miss on Earnings in Q3? Zacks
27-Oct-14 02:50PMWill Noble Corp (NE) Miss Q3 Earnings on Rig Oversupply? Zacks
27-Oct-14 02:40PMWill Crude Price Hit Whiting Petroleum (WLL) Q3 Earnings? Zacks
Alon USA Energy, Inc. operates as an independent refiner and marketer of petroleum products primarily in the South Central, Southwestern, and the Western regions of the United States. The company operates in three segments: Refining and Marketing, Asphalt, and Retail. The Refining and Marketing segment operates sour and heavy crude oil refineries located in Big Spring, Texas, as well as in Paramount, Bakersfield, and Long Beach, California; and a light sweet crude oil refinery located in Krotz Springs, Louisiana with a combined throughput capacity of approximately 214,000 barrels per day. This segment refines crude oil into petroleum products, such as gasoline, diesel fuel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt, and other petroleum-based products. It also markets motor fuels to distributors under the Alon brand; licenses Alon brand name; and provides payment card processing services, advertising programs, and loyalty and other marketing programs to licensed locations. This segment also markets its refined products to other refiners and third parties. The Asphalt segment sells paving asphalt to road and materials manufacturers, and highway construction/maintenance contractors as ground tire rubber, polymer modified, or emulsion asphalt. The Retail segment operates convenience stores that offer various grades of gasoline, diesel fuel, food products, tobacco products, non-alcoholic and alcoholic beverages, and general merchandise to the public primarily under the 7-Eleven and Alon brands. As of March 6, 2014, this segment operated 300 owned and leased convenience store sites primarily in Central and West Texas and New Mexico. The company was founded in 2000 and is headquartered in Dallas, Texas. Alon USA Energy, Inc. is a subsidiary of Alon Israel Oil Company, Ltd.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKeen Kyle CPresident and CEOAug 28Sale16.4517,700291,16588,312Aug 28 04:51 PM
McKeen Kyle CPresident and CEOAug 26Sale16.302,30037,4900Aug 28 04:51 PM
Alon Israel Oil Company, Ltd.10% OwnerAug 20Sale16.36150,0002,454,00037,932,030Aug 22 04:45 PM
Morris Jeff DVice Chairman of the BoardAug 12Sale14.6525,000366,250872,224Aug 12 05:02 PM
Oster MichaelSr. VP-Mergers & AcquisitionsMay 13Sale15.477,500116,025100,528May 13 05:05 PM
TickerANH [NYSE]
CompanyAnworth Mortgage Asset Corporation
CountryUSA
IndustryREIT - Diversified
Market Cap636.33MEPS (ttm)0.34
P/E15.12EPS this Y-26.90%
Forward P/E12.95EPS next Y15.74%
PEG3.02EPS past 5Y-3.30%
P/S3.70EPS next 5Y5.00%
P/B0.84EPS Q/Q-53.30%
Dividend10.89%Sales Q/Q-8.40%
Insider Own0.10%Inst Own60.10%
Insider Trans8.79%Inst Trans0.02%
Short Float3.52%EarningsOct 30/a
Analyst Recom2.90Target Price5.41
Avg Volume908.97K52W Range3.63 - 5.24
20-Oct-14 11:01AMANWORTH MORTGAGE ASSET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
20-Oct-14 09:00AMAnworth Announces Share Repurchase Program and Preferred Dividends Business Wire
30-Sep-14 04:15PMANWORTH MORTGAGE ASSET CORP Files SEC form 8-K, Material Modification to Rights of Security Holders, Other Events, Fi EDGAR Online
30-Sep-14 04:06PMAnworth Announces Increase to Series B Preferred Stock Conversion Rate Benzinga
30-Sep-14 04:06PM4:06 pm Anworth Mortgage announces the conversion rate of the Series B Preferred Stock will increase from 4.0919 shares of Anworth's common stock to 4.1519 shares of its common stock effective Oct 1, 2014 Briefing.com
30-Sep-14 04:05PMAnworth Announces Increase to Series B Preferred Stock Conversion Rate Business Wire
24-Sep-14 04:35PMANWORTH MORTGAGE ASSET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
24-Sep-14 04:25PMAnworth Announces New Hire and Expansion into Residential Mortgage Credit Investments Business Wire
18-Sep-14 04:29PMANWORTH MORTGAGE ASSET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
18-Sep-14 04:23PMAnworth Declares a $0.14 Per Share Third Quarter 2014 Common Dividend Business Wire
Anworth Mortgage Asset Corporation operates as a real estate investment trust in the United States. The company primarily invests in the United States agency mortgage-backed securities, which are securities representing obligations guaranteed by the U.S. government, such as Ginnie Mae, or guaranteed by federally sponsored enterprises comprising Fannie Mae or Freddie Mac. It also invests in collateralized mortgage obligations and mortgage derivative securities. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Anworth Mortgage Asset Corporation was founded in 1997 and is headquartered in Santa Monica, California.
TickerANTH [NASD]
CompanyAnthera Pharmaceuticals, Inc.
CountryUSA
IndustryDrug Manufacturers - Major
Market Cap43.83MEPS (ttm)-3.62
P/E-EPS this Y73.00%
Forward P/E-EPS next Y-18.40%
PEG-EPS past 5Y56.40%
P/S-EPS next 5Y-
P/B3.94EPS Q/Q90.20%
Dividend-Sales Q/Q-
Insider Own0.10%Inst Own57.10%
Insider Trans-56.92%Inst Trans3.61%
Short Float2.33%EarningsOct 30/a
Analyst Recom2.70Target Price3.33
Avg Volume175.89K52W Range1.53 - 3.79
23-Oct-14 04:50PMANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
01-Oct-14 04:57PMANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01-Oct-14 04:00PMAnthera Pharmaceuticals Announces Update on Strategic Partnership Discussions for Blisibimod PR Newswire
22-Aug-14 01:04PMANTHERA PHARMACEUTICALS INC Financials EDGAR Online Financials
14-Aug-14 01:03PMANTHERA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
11-Aug-14 09:41AMAnthera (ANTH) Enters Oversold Territory Zacks
04-Aug-14 08:32AMAnthera Pharmaceuticals (ANTH) Sees Hammer Chart Pattern: Time to Buy? Zacks
29-Jul-14 06:04AMANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online
28-Jul-14 05:40PMAnthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update PR Newswire
21-Jul-14 08:47AMThe Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune Zacks
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing products to treat diseases associated with inflammation and autoimmune diseases. It is developing blisibimod, a Phase III product candidate that targets elevated levels of B-cell activating factor associated with various B-cell mediated autoimmune diseases, including systemic lupus erythematosus, IgA nephropathy, lupus nephritis, multiple myeloma, vasculitis, idiopathic thrombocytopenia purpura, and others. The company was founded in 2004 and is headquartered in Hayward, California.
1 2 3 4 5 6 ... 10 ... 15 next